March 18, 2015
Astellas Pharma said on March 17 that it has filed an application to seek an additional indication for Kiklin Capsules 250 mg (bixalomer). Kiklin is currently indicated for the treatment of hyperphosphatemia in patients on dialysis with chronic kidney disease...read more